Publication
(All)

Author

Subject

6 [sdgs]sdg3

Date issued

11 2000 - 2024

Fulltext

10 no fulltext
1 with fulltext

Results 1-11 of 11 (Search time: 0.115 seconds).

	Issue Date	Title	Author(s)	Source	scopus	WOS	Fulltext/Archive link
1	2014	A novel drug suppresses proliferation of lung cancer cells via increasing the CBL activity and down-regulating epidermal growth factor receptor	Huang, Kuo-Yen; Pan, Szu-Hua; Wang, Wen-Lung; Chen, Ching-Shih; Hong, Tse-Ming; Yang, Pan-Chyr	Cancer Res.	0	0
2	2007	Alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer	Hsu, PI; Chen, CH; Hsieh, CS; Chang, WC; Lai, KH; Lo, GH; Hsu, PN; Tsay, FW; Chen, YS; Hsiao, M; Chen, HC; Lu, PJ	Clin Cancer Res
3	2013	beta-1,4-Galactosyltransferase III Enhances Invasive Phenotypes Via beta 1-Integrin and Predicts Poor Prognosis in Neuroblastoma	Chang, Hsiu-Hao; Chen, Chia-Hua; Chou, Chih-Hsing; Liao, Yung-Feng; Huang, Miao-Juei; Chen, Ya-Hsin; Wang, Wei-Jen; Huang, John; Hung, Ji-Shiang; Ho, Wan-Ling; Jeng, Yung-Ming; Che, Mei-Ieng; Lee, Hsinyu; Lu, Meng-Yao; Yang, Yung-Li; Jou, Shiann-Tarng; Lin, Dong-Tsamn; Lin, Kai-Hsin; Hsu, Wen-Ming; Huang, Min-Chuan	Clin. Cancer Res.
4	2005	Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway.	Lin, M. T.; Zuon, C. Y.; Chang, C. C.; Chen, S. T.; Chen, C. P.; Lin, B. R.; Wang, M. Y.; Jeng, Y. M.; Chang, K. J.; Lee, P. H.; Chen, W. J.; Kuo, M. L.	Clin Cancer Res
5	2014	Development of GADD45 beta (growth arrest DNA damage-inducible gene 45 beta) agonists for the treatment of hepatocellular carcinoma (HCC)	Hsu, Chiun; Ou, Da-Liang; Chen, Kuen-Feng; Lin, Zhong-Zhe; Cheng, Ann-Lii; Shiau, Chung-Wai; 鄭安理	Cancer Res.	0	0
6	2008	Effects of activating epidermal growth factor receptor mutations on clinical response	Gow, Chien-Hung; Chien, Chun-Ru; Chang, Yih-Leong; Chiu, Yueh-Hsai; Kuo, Sung-Hsin; Shih, Jin-Yuan; Chang, Yeun-Chung; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr	Clin Cancer Res
7	2014	High serum transforming growth factor beta 1 levels associated with poor survivals in patients with advanced hepatocellular carcinoma	Lin, Tzu-Hsuan; Shao, Yu-Yun; Chan, Soa-Yu; Huang, Chung-Yi; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理	Cancer Res.	0	0
8	2014	Increased sensitivity to Wnt/beta-catenin inhibitors in hepatocellular carcinoma cells harboring activating mutation of beta-catenin	Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Hsu, Ta-Wen; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理	Cancer Res.	0	0
9	2014	Nuclear expression of BCL10 has a role in the regulation of cell growth and progression of pancreatic cancer through the activation of NF-kappa B-related signaling	Kuo, Sung-Hsin; Yang, Shih-Hung; Yeh, Kun-Huei; Yeh, Pei-Yen; Tien, Yu-Wen; Lee, Hsiao-Wei; Chen, Li-Tzong; Cheng, Ann-Lii; 鄭安理	Cancer Res.	0	0
10	2005	Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.	Sher, YP; Shih, JY; Yang, PC; Roffler, SR; Chu, YW; Wu, CW; Yu, CL; Peck, K.	Clin Cancer Res
11	2013	WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells.	Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理	Cancer Res.